Welcome to OptiMyG
A Prospective International Study Aimed at Transforming the Future for Patients with New-Onset Myasthenia Gravis
Understanding myasthenia gravis
Explore our comprehensive resources and latest publications to deepen your understanding of myasthenia gravis, its symptoms, treatments, and ongoing research
OptiMyG study design
We aim to identify predictors of disease severity,
disease sub-types, and response to
interventions in people with recent onset
myasthenia gravis
ABOUT US
OptiMyG is a pioneering, prospective observational study conducted across Europe, designed to fill a critical gap in myasthenia gravis (MG) research. By establishing a harmonized follow-up structure with systematic sample collections and comprehensive clinical data, OptiMyG aims to uncover disease subtype-specific characteristics, identify predictors of severity, and assess treatment responses in individuals with new-onset MG. This multinational collaboration aspires to deepen our understanding of MG and pave the way for more precise, effective management strategies tailored to each patient’s unique disease profile
Participating centres
Department of Neurology, Karolinska University Hospital, and Karolinska Institutet
Stockholm, Sweden
Coordinating center
Hospital de la Santa Creu i Sant Pau Institut de Recerca
Barcelona, Catalunya, Spain
Department of Neurology, Universitätsspital Basel
Basel,Switzerland
Helsinki University Hospital
Helsinki, Finland
Azienda Ospedaliera Universitaria Careggi
Florence, Italy
University of Warmia and Mazury
Olsztyn, Poland
Warszawski Uniwersytet Medyczny
Warszawa, Poland
This study is led by some of the foremost experts in the field of myasthenia gravis, whose groundbreaking research and extensive clinical experience have significantly advanced our understanding and treatment of the disease. Learn more about their expertise and contributions to the field here.
Contact us
Do not hesitate to reach out for any questions